Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide as part of THE BALANCE GROUP and includes its residence in Mallorca, Spain. It has no verified UK residential location. The British examples are selected official-source services rather than an independent ranking, and their inclusion does not imply identical settings, capabilities or accommodation.

Dual diagnosis generally refers to a substance-use disorder and another mental health disorder occurring in the same person. The term does not identify a single cause or a fixed pair of diagnoses. NIMH explains that overlapping symptoms require careful assessment by professionals familiar with both areas. [1]

Describe what happens during ordinary life: mood, anxiety, sleep, substance use, relationships and responsibilities. Include what changed before, during or after earlier treatment. You do not need to determine which concern came first before asking for help.

Bring an accurate medication list and explain actual use, recent changes and relevant health conditions. A clinician should assess whether symptoms relate to the underlying condition, substances, treatment effects or another concern. The initial plan may need review as more information becomes available.

Castle Craig’s Scottish location, Roehampton’s London hospital setting and COGNIFUL’s Mallorca residence create different clinical and practical choices. Ask each team for the exact pathway rather than assuming all services advertised by an organization form one package.

NIMH describes integrated treatment as combining mental health and substance-use care, potentially involving behavioral therapies, medication and care management. The components should be selected according to assessed needs, not simply added because they appear on a program menu. [1]

Ask who holds an overview of the plan and how professionals share relevant information. If one clinician manages medication and another provides psychotherapy, find out how they review changing symptoms and resolve conflicting recommendations.

The person receiving care should be able to understand the priorities. Ask the team to explain what needs attention now, what is planned for the next phase and what remains uncertain. A long diagnosis list cannot replace that explanation.

Castle Craig describes a dual-diagnosis assessment and a tailored plan within residential addiction treatment. Confirm how that assessment would address the actual mental health concern and what needs would lead the team to recommend another service. [2]

If withdrawal is possible, discuss it before changing use or arranging admission. The clinical team should decide what assessment and setting are required. Do not abruptly stop alcohol or a prescription to prepare for a stay based on an assumption about admission rules.

ASAM identifies alcohol withdrawal management as part of engagement in continuing treatment for alcohol use disorder, not sufficient treatment by itself. A dual-diagnosis plan must also explain how mental health needs are addressed during the ongoing pathway. [5]

For opioid use disorder, CDC recommends evidence-based medication treatment and advises against detoxification alone without it. Ask the relevant addiction clinician how appropriate treatment will be provided or arranged. A preferred residential program should not create an unplanned interruption in necessary care. [6]

COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway. Clinical assessment determines the appropriate care plan and setting. In some cases, treatment may begin with an initial 1–3 days in a partner hospital for observation and stabilization before continuing at COGNIFUL. The pathway is planned around each person’s medical needs. Acute medical, psychiatric or withdrawal needs may require another setting before admission. Clarify the handover and clinical review between services rather than treating detox discharge as automatic residential suitability. [7]

A program should identify what it will do for the assessed mental health concern as well as for substance use. If depression, anxiety or PTSD symptoms are part of the presentation, ask which professionals will evaluate them and what psychological or medical work is proposed.

Do not assume that every symptom will disappear when substance use changes. NIMH describes a complex relationship with effects in more than one direction and shared contributing factors. The team should review the full picture over time rather than rely on a single explanation. [1]

Likewise, improvement in mood does not automatically resolve the substance-use pattern. Ask how both areas and everyday functioning will be reviewed. Different goals may progress at different rates without making the whole plan meaningless.

COGNIFUL’s co-occurring-needs assessment brings together symptoms, substance use, medication, physical health, earlier treatment and functioning. Clinical review determines whether the shared residential setting can meet the combination of needs. The personal plan should explain the proposed work and any care that must be arranged elsewhere. [4]

COGNIFUL Premier and Premier Plus use a residence for a maximum of four clients at any time, each with a private suite. Clinical and bodywork sessions are individual. The residence, chef, personal manager, other holistic sessions, excursions and activities are shared. Discuss the living format and support requirements before deciding that it is appropriate. [8]

The four-client limit describes capacity, not a staffing ratio or proof of medical capability. Ask which professionals are included in your plan, what individual work is proposed and how the team coordinates any separate clinical input. A biography on a shared team page is not a guarantee that every clinician will take part.

COGNIFUL Premier and Premier Plus both include assessment, a personal treatment plan and continuing-care planning. COGNIFUL Premier Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Continuing follow-up in the base program is agreed individually. Typical stays are four to twelve weeks, with the duration reviewed for the person. [9] View program fees

Ask what the additional transition work would address in a UK return plan. The priorities may include coordination with an existing psychiatrist, continuing addiction treatment, family support or practical changes to responsibilities. The program choice should reflect the actual work needed rather than price alone.

COGNIFUL describes continuing-care planning around routines, relationships, local support and authorized professional communication. Confirm the receiving clinicians, first appointments and scope of aftercare. A follow-up period does not establish that every consultation or prescription can be supplied remotely from Spain. [10]

The program generally operates on a self-pay basis and does not bill insurers directly or guarantee reimbursement. Review the written admissions proposal for services, inclusions, total costs and separate arrangements before committing to the clinical pathway and travel.

If a GP, psychiatrist, therapist or addiction service already knows the person, decide how that relationship will be used. With consent, relevant records can help the new team understand earlier assessments and reduce ambiguity.

Ask who remains responsible while the person is in another program and who will provide care afterward. Do not assume an existing clinician will implement a new recommendation without reviewing it. A clear handover includes an opportunity to ask questions.

Arrange the first follow-up appointment before discharge when possible. If the person will return to a different city or work location, include that change in the plan. The actual appointment route should fit where they will live and their ability to attend.

Prescribed treatment, physical dependence, withdrawal and a substance-use disorder are different questions. COGNIFUL’s co-occurring guidance makes that distinction and recommends an accurate account of both instructions and actual use. A universal medication-free rule is not a substitute for assessment. [4]

Clarify who reviews benefits, unwanted effects and interactions, and how monitoring will continue across the treatment sequence. Do not independently change medication because a residence is being considered or because a residential stay has ended.

NIMH describes behavioral approaches, including CBT, motivational interviewing and contingency management, among treatments that can help with co-occurring needs. Their availability and purpose should be discussed with the proposed clinician. A provider should not assume that every method is appropriate or included merely because the service uses an integrated-care label. [1]

Ask how the work relates to the person’s own goals and concerns about change. If earlier treatment was difficult to attend or understand, describe that experience. The next plan should address the barrier instead of interpreting every interruption as unwillingness to participate.

Clarify how individual preferences and clinical recommendations are discussed. The person should understand the purpose of treatment and have a practical way to raise concerns when the approach needs review.

Relatives may help with practical arrangements or participate in agreed clinical work. Ask what each role involves and which information can be shared. A person funding treatment does not automatically determine access to the full clinical history.

If family sessions are proposed, they should have a purpose linked to the assessment and the person’s consent. Discuss how the provider handles disagreement or relationships that are not appropriate to involve in the same way.

Ask how the team assesses substance use, mental health symptoms, participation and daily functioning together. A single improvement should not be treated as proof that every goal has been achieved.

Discuss how the plan changes after a setback or when new information emerges. The response should include a clinical review of needs, safety and support rather than pressure to present a perfect recovery account.

Before discharge, request a concise explanation of the next stage. It should identify the professionals, appointments, medication responsibilities and outstanding questions. Continuing care becomes more useful when those responsibilities are concrete.

Must the mental health condition be treated before the addiction?

The sequence depends on the assessment, immediate needs and appropriate care level. A coordinated plan should address both concerns and explain any priorities rather than apply one rule to everyone.

Does every residential program provide medical detox?

Confirm the exact service. COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway.

Can I continue prescribed psychiatric medication?

That requires an individual clinical review. Do not assume a program requires stopping all prescriptions. Ask who will assess the treatment and provide monitoring and continuity.

What should a UK resident ask before choosing Mallorca?

Ask why the residence fits, what care is required first, which professionals are included and how UK follow-up will work. The complete clinical and financial proposal should be clear before travel is arranged.

1. Finding Help for Co-Occurring Substance Use and Mental Disorders — National Institute of Mental Health.
2. Addiction Treatment in Dual Diagnosis — Castle Craig.
3. Priory Hospital Roehampton — Priory.
4. Private Dual Diagnosis Treatment and Co-Occurring Needs — COGNIFUL.
5. Clinical Practice Guideline on Alcohol Withdrawal Management — American Society of Addiction Medicine.
6. Opioid Use Disorder: Treating — Centers for Disease Control and Prevention.
7. Clinical Scope, Suitability and Care Coordination — COGNIFUL.
8. How Residential Treatment Works — COGNIFUL.
9. Programs, Fees and Admissions — COGNIFUL.
10. Continuing Care and Reintegration — COGNIFUL.